{
    "title": "Individual feed for https://www.npr.org/rss/rss.php?id=1128",
    "link": "https://www.npr.org/rss/rss.php?id=1128",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-23T11:02:26.296302",
    "items": [
        {
            "title": "Scientists learn more about how human embryos implant using artificial wombs",
            "link": "https://www.npr.org/2025/12/23/nx-s1-5646649/human-embryos-implantation-artificial-womb",
            "description": "Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occ...",
            "pubDate": "2025-12-23T16:00:00",
            "image_url": "https://npr.brightspotcdn.com/dims3/default/strip/false/crop/700x700+0+0/resize/700x700!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F38%2Fdb%2F2f3e384749048179e88a0e18c272%2Fembryo.jpg"
        },
        {
            "title": "It's the 'gold standard' in autism care. Why are states reining it in?",
            "link": "https://www.npr.org/sections/shots-health-news/2025/12/23/nx-s1-5643014/autism-aba-therapy-medicaid-costs",
            "description": "Budget shortfalls and nearly $1 trillion in looming federal Medicaid cuts have prompted states to rein in spending on a widely embraced autism therapy...",
            "pubDate": "2025-12-23T11:00:00",
            "image_url": "https://npr.brightspotcdn.com/dims3/default/strip/false/crop/8192x5464+0+0/resize/8192x5464!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fa3%2F29%2F5b790bef404ab37300622d2b5383%2Fautism-medicaid-osborne-05.jpg"
        },
        {
            "title": "U.S. regulators approve Wegovy pill for weight loss",
            "link": "https://www.npr.org/2025/12/23/g-s1-103424/us-approve-pill-for-weight-loss",
            "description": "U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat ...",
            "pubDate": "2025-12-23T10:27:45",
            "image_url": "https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5076x3384+0+0/resize/5076x3384!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fe5%2F23%2F3e1c94ad4ecd89ebeab43001b5b9%2Fap25343789565858.jpg"
        },
        {
            "title": "GLP-1s don't always work for weight loss. Researchers are trying to figure out why",
            "link": "https://www.npr.org/2025/12/22/nx-s1-5630071-e1/glp-1s-dont-always-work-for-weight-loss-researchers-are-trying-to-figure-out-why",
            "description": "GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the ...",
            "pubDate": "2025-12-22T21:16:54",
            "image_url": "https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=nx-s1-5630071-e1"
        },
        {
            "title": "Some patients face hurdles getting HIV prevention drugs. Here's what to know",
            "link": "https://www.npr.org/2025/12/22/nx-s1-5645054/hiv-prevention-drug-prep-billing",
            "description": "A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches a...",
            "pubDate": "2025-12-22T10:00:00",
            "image_url": "https://npr.brightspotcdn.com/dims3/default/strip/false/crop/3840x2160+0+0/resize/3840x2160!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fee%2Fbd%2F83f914b74367ab77582e5bc8a89d%2Fhelpline3-leadart.jpg"
        }
    ]
}